Dr. Wright is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215Phone+1 617-632-4244Fax+1 617-632-4897
Education & Training
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 2006 - 2010
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Pediatrics, 2003 - 2006
- Lewis Katz School of Medicine at Temple UniversityClass of 2003
Certifications & Licensure
- TN State Medical License 2006 - 2026
- MA State Medical License 2016 - 2025
- VT State Medical License 2003 - 2006
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma Start of enrollment: 2018 Aug 01
Publications & Presentations
PubMed
- 17 citationsFeasibility and Efficacy of a Computer-Based Intervention Aimed at Preventing Reading Decoding Deficits Among Children Undergoing Active Treatment for Medulloblastoma:...Shawna L. Palmer, Laurie Leigh, Susan C. Ellison, Arzu Onar-Thomas, Shengjie Wu
Journal of Pediatric Psychology. 2014-05-01 - 25 citationsRevisiting the Role of Radiation Therapy for Pediatric Low-Grade GliomaDanielle S. Bitterman, Shannon M. MacDonald, Torunn I. Yock, Nancy J. Tarbell, Karen Wright
Journal of Clinical Oncology. 2019-09-09 - 279 citationsCross-species genomics matches driver mutations and cell compartments to model ependymomaRobert A. Johnson, Karen Wright, Helen Poppleton, Kumarasamypet M. Mohankumar, David Finkelstein
Nature. 2010-07-29
Press Mentions
- First-of-Their-Kind Findings Turn Conventional Wisdom About Diffuse Hemispheric Glioma on Its HeadOctober 22nd, 2024
- Adolescent Glioma Subtype Responds to CDK4/6 InhibitorSeptember 3rd, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: